Poland Seeks to Get Stake in Surveillance-Satellite Maker Iceye
Vinci SA, an investment vehicle of the country's state development bank BGK, is in final talks to acquire Iceye's convertible debt in the ongoing funding round, according to people familiar with the process, who didn't disclose the size of the potential transaction. The investment will support the company's plans to expand production as well as research and development facilities in Poland, they said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Luxchem Corporation Berhad (KLSE:LUXCHEM) Stock Goes Ex-Dividend In Just Three Days
Luxchem Corporation Berhad (KLSE:LUXCHEM) is about to trade ex-dividend in the next three days. The ex-dividend date generally occurs two days before the record date, which is the day on which shareholders need to be on the company's books in order to receive a dividend. The ex-dividend date is important as the process of settlement involves at least two full business days. So if you miss that date, you would not show up on the company's books on the record date. Thus, you can purchase Luxchem Corporation Berhad's shares before the 7th of August in order to receive the dividend, which the company will pay on the 29th of August. The company's next dividend payment will be RM00.007 per share, and in the last 12 months, the company paid a total of RM0.014 per share. Looking at the last 12 months of distributions, Luxchem Corporation Berhad has a trailing yield of approximately 3.3% on its current stock price of RM00.42. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. So we need to investigate whether Luxchem Corporation Berhad can afford its dividend, and if the dividend could grow. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Dividends are usually paid out of company profits, so if a company pays out more than it earned then its dividend is usually at greater risk of being cut. That's why it's good to see Luxchem Corporation Berhad paying out a modest 42% of its earnings. Yet cash flow is typically more important than profit for assessing dividend sustainability, so we should always check if the company generated enough cash to afford its dividend. It paid out more than half (63%) of its free cash flow in the past year, which is within an average range for most companies. It's positive to see that Luxchem Corporation Berhad's dividend is covered by both profits and cash flow, since this is generally a sign that the dividend is sustainable, and a lower payout ratio usually suggests a greater margin of safety before the dividend gets cut. View our latest analysis for Luxchem Corporation Berhad Click here to see how much of its profit Luxchem Corporation Berhad paid out over the last 12 months. Have Earnings And Dividends Been Growing? Companies that aren't growing their earnings can still be valuable, but it is even more important to assess the sustainability of the dividend if it looks like the company will struggle to grow. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. That explains why we're not overly excited about Luxchem Corporation Berhad's flat earnings over the past five years. It's better than seeing them drop, certainly, but over the long term, all of the best dividend stocks are able to meaningfully grow their earnings per share. The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. Luxchem Corporation Berhad has delivered an average of 0.5% per year annual increase in its dividend, based on the past 10 years of dividend payments. Final Takeaway Should investors buy Luxchem Corporation Berhad for the upcoming dividend? Earnings per share are down very slightly in recent times, and Luxchem Corporation Berhad paid out less half its profit and more than half its cash flow as dividends, which is not the worst combination but could be better. To summarise, Luxchem Corporation Berhad looks okay on this analysis, although it doesn't appear a stand-out opportunity. If you're not too concerned about Luxchem Corporation Berhad's ability to pay dividends, you should still be mindful of some of the other risks that this business faces. For example, we've found 2 warning signs for Luxchem Corporation Berhad (1 is a bit concerning!) that deserve your attention before investing in the shares. A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
7 minutes ago
- Yahoo
Southern Acids (M) Berhad (KLSE:SAB) Is Paying Out A Dividend Of MYR0.05
The board of Southern Acids (M) Berhad (KLSE:SAB) has announced that it will pay a dividend on the 11th of November, with investors receiving MYR0.05 per share. This payment means the dividend yield will be 1.5%, which is below the average for the industry. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Southern Acids (M) Berhad's Projected Earnings Seem Likely To Cover Future Distributions Even a low dividend yield can be attractive if it is sustained for years on end. However, Southern Acids (M) Berhad's earnings easily cover the dividend. This means that most of what the business earns is being used to help it grow. Over the next year, EPS could expand by 2.8% if recent trends continue. If the dividend continues along recent trends, we estimate the payout ratio will be 18%, which is in the range that makes us comfortable with the sustainability of the dividend. Check out our latest analysis for Southern Acids (M) Berhad Southern Acids (M) Berhad Has A Solid Track Record The company has been paying a dividend for a long time, and it has been quite stable which gives us confidence in the future dividend potential. The last annual payment of MYR0.05 was flat on the annual payment from10 years ago. Dividends have grown relatively slowly, which is not great, but some investors may value the relative consistency of the dividend. Dividend Growth May Be Hard To Achieve Some investors will be chomping at the bit to buy some of the company's stock based on its dividend history. Earnings have grown at around 2.8% a year for the past five years, which isn't massive but still better than seeing them shrink. Earnings growth is slow, but on the plus side, the dividend payout ratio is low and dividends could grow faster than earnings, if the company decides to increase its payout ratio. Southern Acids (M) Berhad Looks Like A Great Dividend Stock Overall, we like to see the dividend staying consistent, and we think Southern Acids (M) Berhad might even raise payments in the future. The company is easily earning enough to cover its dividend payments and it is great to see that these earnings are being translated into cash flow. All of these factors considered, we think this has solid potential as a dividend stock. It's important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. For instance, we've picked out 1 warning sign for Southern Acids (M) Berhad that investors should take into consideration. Looking for more high-yielding dividend ideas? Try our collection of strong dividend payers. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
Baxter International (BAX) Falls to New Low on Disappointing Growth Forecast
We recently published . Baxter International Inc. (NYSE:BAX) is one of the worst-performing stocks on Thursday. Baxter International dropped its share prices to a new 52-week low on Thursday, as investors soured on its lower earnings growth forecast. At intra-day trading, shares of Baxter International Inc. (NYSE:BAX) dropped to their lowest price of $21.47 before ending the day down by 22.42 percent at $21.76 apiece. In a call with analysts, Baxter International Inc. (NYSE:BAX) said it lowered its adjusted EPS to between $2.42 and $2.52 from the $2.47 to $2.55. Analysts expected $2.52 per share. 'While we never want to lower expectations, our overall objective is reducing the outlook to capture more of the potential downside risks,' Baxter International Inc. (NYSE:BAX) CFO Joel Grade was quoted as saying, underscoring the demand weakness for IV fluids. Pixabay / Public Domain In the second quarter of the year, Baxter International Inc. (NYSE:BAX) swung to a net income attributable to shareholders of $91 million from a $314 million net loss in the same period last year. Net sales inched up by 4 percent to $2.8 billion from $2.69 billion. While we acknowledge the potential of BAX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
